|
J&J-Pfizer Drug Seen as Long Shot Against Alzheimer’s
When 70-year-old Bill Price signed on in 2006 to become one of the early testers of the Alzheimer’s drug bapineuzumab, he held high hopes the injections would stop the disease that was starting to claim his memory.
Bloomberg |
Register Now
Archives